Application of Explainable AI in Chronic Kidney Disease Prediction: SHAP Method-Driven Clinical Decision Support

This article introduces a chronic kidney disease (CKD) prediction framework based on decision trees and SHAP explainability technology, aiming to solve the 'black box' dilemma of medical AI and balance model transparency and clinical usability. The core goal of the project is to develop a high-performance and explainable CKD prediction model, identify key clinical risk factors, and provide support for clinical decision-making.

Artificial intelligence is widely used in the medical field, but most high-performance models are 'black boxes' that cannot explain the basis for their decisions, which brings issues such as trust and regulation in medical scenarios. Chronic kidney disease has no obvious early symptoms, so early prediction is crucial. However, risk factors are complex, traditional methods are difficult to capture nonlinear relationships, and machine learning needs explainability to be practical.

The project uses the CKD dataset from the UCI Machine Learning Repository (400 samples, 24 clinical features), covering blood, physiological, urine indicators, and medical history. A decision tree was selected as the basic classifier (naturally readable rules). The model's test set performance is excellent: accuracy, precision, recall, F1, and ROC-AUC are all 1.00, and the cross-validation score is 0.97 (suggesting possible limitations of the test set).

SHAP quantifies feature contributions based on the game theory Shapley value. Global analysis identifies key risk factors: hemoglobin (most influential, related to anemia), urine specific gravity (reflects renal concentration function), hypertension, and blood urea. Local explanations can show individual patients the direction and degree of influence of each feature on the prediction, helping with personalized decision-making.

The project provides multiple visualizations: decision trees show decision paths; SHAP summary plots present global feature importance; confusion matrices and ROC curves evaluate performance; feature importance plots intuitively show contributions. These tools help doctors understand the model and also support doctor-patient communication.

Explainability helps build doctor trust (consistent with medical knowledge), serves as a medical education tool, discovers model errors to ensure quality, and meets regulatory compliance (such as FDA guidelines).

Project limitations include dataset size, etc. Future improvements can include expanding models (random forest, XGBoost), optimizing hyperparameters, multi-center external validation, calibration analysis, developing deployment systems, extending to other diseases, and exploring other explanation technologies (such as LIME).

Explainable AI is the inevitable path for the development of medical AI. This project demonstrates the value of combining high-performance machine learning with clinical explainability. The key factors identified by SHAP are consistent with clinically concerned indicators, providing clear decision support for doctors. We look forward to more explainable medical AI systems serving patients' health.